Skip to main content

Peer Review reports

From: Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

Original Submission
17 Jan 2020 Submitted Original manuscript
24 Mar 2020 Author responded Author comments - Wei Fang Dai
26 Feb 2020 Reviewed Reviewer Report - Giovanni Grignani
29 Feb 2020 Reviewed Reviewer Report - Zhihua Kang
Resubmission - Version 2
24 Mar 2020 Submitted Manuscript version 2
Publishing
27 Mar 2020 Editorially accepted
15 Apr 2020 Article published 10.1186/s12885-020-06798-1

You can find further information about peer review here.

Back to article page